The cumulative analgesic effect of repeated electroacupuncture is modulated by Adora3 in the SCDH of mice with neuropathic pain

Abstract

Background: Existing remedial approaches for relieving neuropathic pain (NPP) are challenging and open the way for alternative therapeutic measures such as electroacupuncture (EA). The mechanism underlying the antinociceptive effects of repeated EA sessions, particularly concerning the regulation of the Adora3 receptor and its associated enzymes, has remained elusive.

Methods: This study used a mouse model of spared nerve injury (SNI) to explore the cumulative analgesic effects of repeated EA at ST36 (Zusanli) and its impact on Adora3 regulation in the spinal cord dorsal horn (SCDH). Forty-eight male mice underwent SNI surgery for induction of neuropathic pain and were randomly assigned to the SNI, SNI + 2EA, SNI + 4EA, and SNI + 7EA groups. Spinal cord (L4–L6) was sampled for immunofluorescence, adenosine (ADO) detection and for molecular investigations following repeated EA treatment.

Results: Following spared nerve injury (SNI), there was a significant decrease in mechanical withdrawal thresholds (PWTs) and thermal nociceptive withdrawal latency (TWL) in the ipsilateral hind paw on the third day post-surgery, while the contralateral hind paw PWTs showed no significant changes. On subsequent EA treatments, the SNI + EA groups led to a significant increase in pain thresholds (p < 0.05). Repeated EA sessions in SNI mice upregulated Adenosine A3 (Adora3) and cluster of differentiation-73 (CD73) expression while downregulating adenosine deaminase (ADA) and enhancing neuronal instigation in the SCDH. Colocalization analysis of Neun-treated cells revealed increased Adora3 expression, particularly in the SNI + 7EA group.

Conclusions: In conclusion, cumulative electroacupuncture treatment reduced neuropathic pain by regulating Adora3 and CD73 expression, inhibiting ADA and most likely increasing neuronal activation in the SCDH. This study offers a promising therapeutic option for managing neuropathic pain, paving the way for further research.

Keywords

Adora3 / antinociception / electroacupuncture / lumbar spinal cord / neuropathic pain

References

[1] Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021; 101(1): 259-301.

[2] Bannister K, Sachau J, Baron R, Dickenson AH. Neuropathic pain: mechanism-based therapeutics. Annu Rev Pharmacol Toxicol. 2020; 60: 257-274.

[3] van Velzen M, Dahan A, Niesters M. Neuropathic pain: challenges and opportunities. Front Pain Res (Lausanne). 2020; 1: 1.

[4] Johnson MI. The clinical effectiveness of acupuncture for pain relief-you can be certain of uncertainty. Acupunct Med. 2006; 24(2): 71-79.

[5] Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain. 2018; 19(5): 455-474.

[6] Kligler B, Nielsen A, Kohrherr C, et al. Acupuncture therapy in a group setting for chronic pain. Pain Med. 2018; 19(2): 393-403.

[7] Lv ZT, Shen LL, Zhu B, et al. Effects of intensity of electroacupuncture on chronic pain in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Res Ther. 2019; 21: 1-10.

[8] Zhang R, Lao L, Ren K, Berman BM. Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology. 2014; 120(2): 482-503.

[9] Cohen SP, Mao JJB. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014; 348: f7656.

[10] Dunwiddie TV, Masino SAJA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001; 24(1): 31-55.

[11] Little JW, Ford A, Symons-Liguori AM, et al. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Brain. 2015; 138(1): 28-35.

[12] Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol. 1998; 347(1): 1-11.

[13] Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal. 2006; 2(2): 351-360.

[14] Pettengill M, Robson S, Tresenriter M, et al. Soluble ecto-5′-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. J Biol Chem. 2013; 288(38): 27315-27326.

[15] Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000; 87(2): 149-158.

[16] Laferriere CA, Pang DS. Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents. J Am Assoc Lab Anim Sci. 2020; 59(3): 254-263.

[17] Kwilasz AJ, Ellis A, Wieseler J, et al. Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A_2A receptor agonists. Brain Behav Immun. 2018; 69: 470-479.

[18] Wang Q, Qin F, Wang H, et al. Effect of electro-acupuncture at ST36 and SP6 on the cAMP-CREB pathway and mRNA expression profile in the brainstem of morphine tolerant mice. Front Neurosci. 2021; 15: 698967.

[19] Chaplan SR, Bach FW, Pogrel J, Chung J, Yaksh T. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53(1): 55-63.

[20] Wan J, Nan S, Liu J, et al. Synaptotagmin 1 is involved in neuropathic pain and electroacupuncture-mediated analgesic effect. Int J Mol Sci. 2020; 21(3): 968.

[21] Navratilova E, Morimura K, Xie JY, Atcherley CW, Ossipov MH, Porreca F. Positive emotions and brain reward circuits in chronic pain. J Comp Neurol. 2016; 524(8): 1646-1652.

[22] Bates D, Schultheis BC, Hanes MC, et al. A comprehensive algorithm for management of neuropathic pain. Pain Med. 2019; 20(Suppl 1): S2-s12.

[23] Daniel HC, Narewska J, Serpell M, Hoggart B, Johnson R, Rice AS. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioral pain management programs. Eur J Pain. 2008; 12(6): 731-741.

[24] Miller LR, Cano A. Comorbid chronic pain and depression: who is at risk? J Pain. 2009; 10(6): 619-627.

[25] Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol. 2010; 229(1-2): 26-50.

[26] Ji R-R, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013; 154: S10-S28.

[27] Attal N, Bouhassira D. Advances in the treatment of neuropathic pain. Curr Opin Neurol. 2021; 34(5): 631-637.

[28] Qin Z, Liu X, Yao Q, Zhai Y, Liu Z. Acupuncture for treating sciatica: a systematic review protocol. BMJ Open. 2015; 5(4): e007498.

[29] Sun N, Wang LQ, Shao JK, et al. An expert consensus to standardize acupuncture treatment for knee osteoarthritis. Acupunct Med. 2020; 38(5): 327-334.

[30] Yan L, Wu X, Yin Z, Ma C. Effect of electroacupuncture on the levels of amino acid neurotransmitters in the spinal cord in rats with chronic constrictive injury. Zhen Ci Yan Jiu. 2011; 36(5): 353-379.

[31] Chen S, Wang S, Rong P, et al. Acupuncture for visceral pain: neural substrates and potential mechanisms. Evid Based Complement Alternat Med. 2014; 2014: 1-12.

[32] Sowa NA, Taylor-Blake B, Zylka MJ. Ecto-5′-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. J Neurosci. 2010; 30(6): 2235-2244.

[33] Street SE, Walsh PL, Sowa NA, et al. PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain. 2011; 7: 80.

[34] Chen JF, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets—what are the challenges? Nat Rev Drug Discov. 2013; 12(4): 265-286.

[35] Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V. Adenosine receptors: expression, function and regulation. Int J Mol Sci. 2014; 15(2): 2024-2052.

[36] Zylka MJ. Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med. 2011; 17(4): 188-196.

[37] Eisenstein A, Chitalia SV, Ravid K. Bone marrow and adipose tissue adenosine receptors effect on osteogenesis and adipogenesis. Int J Mol Sci. 2020; 21(20): 7470.

[38] Jacobson KA, Tosh DK, Jain S, Gao Z-G. Historical and current adenosine receptor agonists in preclinical and clinical development. Front Cell Neurosci. 2019; 13: 124.

[39] Fishman P. Drugs targeting the A3 adenosine receptor: human clinical study data. Molecules. 2022; 27(12): 3680.

[40] Janes K, Esposito E, Doyle T, et al. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. Pain. 2014; 155(12): 2560-2567.

[41] Ford A, Castonguay A, Cottet M, et al. Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain. J Neurosci. 2015; 35(15): 6057-6067.

[42] Richner M, Bjerrum OJ, Nykjaer A, Vaegter CB. The spared nerve injury (SNI) model of induced mechanical allodynia in mice. J Vis Exp. 2011; 54: 3092.

[43] Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988; 33(1): 87-107.

[44] Wang JY, Meng FY, Chen SP, Gao YH, Liu JL. Analysis on interrelation between electroacupuncture-induced cumulative analgesic effect and hypothalamic cholinergic activities in chronic neuropathic pain rats. Chin J Integr Med. 2012; 18: 699-707.

[45] Kan Y, Chen SP, Gao YH, et al. Involvement of hippocampal NO/PKG signaling pathway in the accumulative analgesic effect of electroacupuncture stimulation of “Zusanli” (ST 36)- “Yanglingquan” (GB 34) in chronic neuropathic pain rats. Zhen Ci Yan Jiu. 2013; 38(2): 93-99.

[46] Yang X, Wang Y, Gao X. Effects of electroacupuncture on hyperalgesia score of neuropathic pain rats. Acupunct Res. 2002; 27(1): 60-63.

[47] Xu Q, Liu T, Chen S, et al. The cumulative analgesic effect of repeated electroacupuncture involves synaptic remodeling in the hippocampal CA3 region. Neural Regen Res. 2012; 7(18): 1378-1385.

[48] Wang JY, Chen SP, Gao YH, Qiao LN, Zhang JL, Liu JL. Effect of repeated electroacupuncture intervention on hippocampal ERK and p38MAPK signaling in neuropathic pain rats. Evid Based Complement Alternat Med. 2015; 2015: 1-10.

[49] Choi JW, Kang SY, Choi JG, et al. Analgesic effect of electroacupuncture on paclitaxel-induced neuropathic pain via spinal opioidergic and adrenergic mechanisms in mice. Am J Chin Med. 2015; 43(1): 57-70.

[50] Chen Z, Janes K, Chen C, et al. Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J. 2012; 26(5): 1855-1865.

[51] Terayama R, Yamamoto Y, Kishimoto N, et al. Peripheral nerve injury activates convergent nociceptive input to dorsal horn neurons from neighboring intact nerve. Exp Brain Res. 2015; 233(4): 1201-1212.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.